However, from these pathway 1 genes, only a TXNRD1 selenoprotein variant (rs11111979), one of the three thioredoxin reductases which function in redox control [8], remained borderline significant for an increased CRC risk when applying gene-wide variance considerations by the PACT method. The gene discussed is TXNRD1; the disease is colorectal carcinoma.